| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.18 | 0.01 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.094 | 0.01 |